_edited.jpg)
Featured Products
At CXDX we bring together evidence-based technology, tools and partnerships to help clinicians, teams and organisations see what’s really happening inside the brain and body. From rapid ERP-based brain assessments and cognitive training platforms to portable VO₂ testing, oculomotor screening and targeted nutrition, our portfolio is built to support better decisions at the point of care and in high-performance environments.
We don’t just “resell” devices – we curate and support an integrated toolkit.
BRAIN & COGNITIVE TECHNOLOGIES
NeuroCatch® Platform
Rapid, portable brain-function assessment using ERPs to objectively track N100, P300 and N400 “brain vital signs” in under 10 minutes. NeuroCatch measures the brain in action.
It is included in the Australian Therapeutic Goods Register (ARTG #439393) and is intended for the elicitation, acquisition, analysis, storage, reporting and management of electroencephalograph (EEG) and event-related potential (ERP) information to aid in diagnosis of a patient
An end-to-end concussion education and case-management platform connecting clinics, teams and athletes with consistent, evidence-based care
3D cognitive training system that enhances attention, awareness and decision-making through scientifically validated multiple-object tracking
Flow Neuroscience is a medically approved, at-home brain stimulation headset and app-based program that uses gentle transcranial direct current stimulation (tDCS) and behavioural support to help treat symptoms of depression.
It is included in the Australian Therapeutic Goods Register (ARTG #509725) and is intended for the treatment of mental and neurological disorders (Depression) for adults (18+) diagnosed with Major Depressive Disorder (MDD). The device is only to be used under the supervision of an appropriately qualified health practitioner.
CARDIAC, PERFORANCE & PHYSIOLOGY
The Arrhythmia Monitor System (ARTG#519567) is a wrist-worn device with a connected data management service that uses optical pulse monitoring at rest and intermittent single-lead (Lead I) ECG recordings to assist in the diagnosis, screening and monitoring of atrial fibrillation and other cardiac arrhythmias in everyday or hospital settings